南京医药
(600713)
| 流通市值：68.08亿 | | | 总市值：69.24亿 |
| 流通股本：12.87亿 | | | 总股本：13.09亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,305,395,534.94 | 4,562,612,055.88 | 1,159,037,620.22 | 2,461,628,969.23 |
| 应收票据及应收账款 | 17,494,810,620.82 | 12,582,396,506.15 | 17,892,364,178.11 | 15,654,020,297.91 |
| 其中：应收票据 | 1,079,210,227.04 | 572,086,054.27 | 938,917,203.01 | 1,069,085,679.79 |
| 应收账款 | 16,415,600,393.78 | 12,010,310,451.88 | 16,953,446,975.1 | 14,584,934,618.12 |
| 应收款项融资 | 2,162,327,317.66 | 2,515,275,629.48 | 2,827,220,190.01 | 2,932,913,972.19 |
| 预付款项 | 991,831,195.07 | 889,508,713.42 | 882,635,324.86 | 1,025,463,473.28 |
| 其他应收款合计 | 810,848,658.59 | 812,089,253.74 | 719,609,065.66 | 844,940,981.96 |
| 存货 | 6,276,599,451.46 | 6,285,916,964.92 | 6,027,962,471.23 | 5,912,948,177.72 |
| 其他流动资产 | 134,354,436.97 | 160,062,617.01 | 125,849,085.43 | 129,939,037.3 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 30,516,521,104.4 | 27,807,861,740.6 | 29,634,677,935.52 | 28,961,854,909.59 |
| 非流动资产: | | | | |
| 长期股权投资 | 70,054,150.73 | 70,566,432.63 | 68,647,113.89 | 68,415,493.91 |
| 其他权益工具投资 | 202,049,568.24 | 212,900,078.14 | 235,360,656.24 | 188,184,526.24 |
| 投资性房地产 | 88,888,834.93 | 89,281,397.55 | 93,899,226.98 | 92,107,520.54 |
| 固定资产 | 1,402,981,219.99 | 1,415,854,506.28 | 1,095,105,014.56 | 1,102,404,109.9 |
| 在建工程 | 262,924,740.37 | 237,272,905.69 | 193,237,869.59 | 138,651,402.32 |
| 使用权资产 | 340,567,202.71 | 232,079,672.03 | 233,170,635.29 | 238,263,476.07 |
| 无形资产 | 211,278,511.8 | 215,684,191.83 | 216,076,787.53 | 217,383,033.28 |
| 开发支出 | 21,849,873.95 | 18,437,891.78 | 16,843,225.14 | - |
| 商誉 | 72,166,924.65 | 72,166,924.65 | 72,166,924.65 | 72,166,924.65 |
| 长期待摊费用 | 44,481,732.46 | 44,630,617 | 47,271,830.75 | 46,401,791.14 |
| 递延所得税资产 | 232,195,688.73 | 243,434,087.67 | 245,996,908.45 | 227,662,488.23 |
| 其他非流动资产 | 13,489,702.42 | 13,456,486.67 | 301,653,110.67 | 301,955,186.89 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,962,928,150.98 | 2,865,765,191.92 | 2,819,429,303.74 | 2,693,595,953.17 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 33,479,449,255.38 | 30,673,626,932.52 | 32,454,107,239.26 | 31,655,450,862.76 |
| 流动负债: | | | | |
| 短期借款 | 4,477,208,119.57 | 2,044,519,083.58 | 4,307,463,335.83 | 4,567,877,942.38 |
| 应付票据及应付账款 | 10,059,399,785.61 | 10,175,570,479.87 | 9,857,776,481.99 | 9,592,321,846.29 |
| 其中：应付票据 | 2,598,019,480.88 | 2,824,699,028.16 | 2,169,594,359.89 | 2,414,825,985.69 |
| 应付账款 | 7,461,380,304.73 | 7,350,871,451.71 | 7,688,182,122.1 | 7,177,495,860.6 |
| 合同负债 | 276,044,079.98 | 278,668,232.77 | 205,679,565.78 | 191,527,486.54 |
| 应付职工薪酬 | 158,758,946.06 | 240,577,997.14 | 167,624,976.13 | 159,821,030.54 |
| 应交税费 | 177,370,549.38 | 216,510,402.2 | 189,560,503.18 | 193,440,483.85 |
| 其他应付款合计 | 2,773,775,735.04 | 2,003,792,287.23 | 2,884,546,039.26 | 2,111,177,078.47 |
| 一年内到期的非流动负债 | 79,238,470.65 | 980,609,433.81 | 963,127,986.78 | 2,176,064,566.6 |
| 其他流动负债 | 1,625,444,068.47 | 1,153,464,610.31 | 1,153,885,607.33 | 1,147,844,836.97 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 19,627,239,754.76 | 17,093,712,526.91 | 19,729,664,496.28 | 20,140,075,271.64 |
| 非流动负债: | | | | |
| 长期借款 | 200,000,000 | 200,000,000 | 648,481,100 | 648,481,100 |
| 应付债券 | 5,113,621,407.02 | 5,139,167,483.9 | 4,049,409,462.99 | 3,022,655,686.32 |
| 租赁负债 | 226,030,861.91 | 116,178,710.59 | 123,428,998.96 | 116,478,812.81 |
| 递延收益 | 273,563,417.15 | 277,616,419.57 | 281,746,332.82 | 286,031,079.32 |
| 递延所得税负债 | 32,434,136.15 | 59,053,677.54 | 75,080,460.94 | 54,263,851.66 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,845,649,822.23 | 5,792,016,291.6 | 5,178,146,355.71 | 4,127,910,530.11 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 25,472,889,576.99 | 22,885,728,818.51 | 24,907,810,851.99 | 24,267,985,801.75 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,309,326,040 | 1,309,326,040 | 1,309,326,040 | 1,309,326,040 |
| 其他权益工具 | 8,939,046.75 | 8,939,046.75 | - | - |
| 资本公积 | 2,467,121,972.6 | 2,465,733,066.47 | 2,464,095,970.02 | 2,461,968,462.9 |
| 减:库存股 | 12,125,532.26 | 20,903,333.6 | 21,924,340.4 | 21,924,340.4 |
| 其他综合收益 | 95,418,435.44 | 102,296,529.74 | 116,881,567.43 | 81,613,701.8 |
| 盈余公积 | 322,368,865.27 | 322,368,865.27 | 278,488,716.62 | 278,488,716.62 |
| 未分配利润 | 2,827,627,765.5 | 2,650,266,792.49 | 2,565,401,778.76 | 2,434,840,611.66 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,018,676,593.3 | 6,838,027,007.12 | 6,712,269,732.43 | 6,544,313,192.58 |
| 少数股东权益 | 987,883,085.08 | 949,871,106.89 | 834,026,654.84 | 843,151,868.43 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,006,559,678.38 | 7,787,898,114.01 | 7,546,296,387.27 | 7,387,465,061.01 |
| 负债和股东权益合计 | 33,479,449,255.38 | 30,673,626,932.52 | 32,454,107,239.26 | 31,655,450,862.76 |
| 公告日期 | 2025-04-30 | 2025-04-10 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |